Cholesterinum Plex

Cholesterinum, Cholesterinum, Hepatinum, Pulminum

Seroyal Usa
Human Otc Drug
NDC 62106-1207

Cholesterinum Plex also known as Cholesterinum, Cholesterinum, Hepatinum, Pulminum is a human otc drug labeled by 'Seroyal Usa'. National Drug Code (NDC) number for Cholesterinum Plex is 62106-1207. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Cholesterinum Plex drug includes Cholesterol - 9 [hp_C]/30mL Oryctolagus Cuniculus Liver - 7 [hp_C]/30mL Oryctolagus Cuniculus Lung - 7 [hp_C]/30mL . The currest status of Cholesterinum Plex drug is Active.

Drug Information:

Drug NDC:	62106-1207
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Cholesterinum Plex
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Cholesterinum, Cholesterinum, Hepatinum, Pulminum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Seroyal Usa
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	CHOLESTEROL - 9 [hp_C]/30mL ORYCTOLAGUS CUNICULUS LIVER - 7 [hp_C]/30mL ORYCTOLAGUS CUNICULUS LUNG - 7 [hp_C]/30mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	16 Aug, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Seroyal USA
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	97C5T2UQ7J 7A99K6361Z 857C5Q4J3H
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
62106-1207-0	1 BOTTLE, GLASS in 1 CARTON (62106-1207-0) / 30 mL in 1 BOTTLE, GLASS	16 Aug, 2017	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Cholesterinum Plex

Cholesterinum, Cholesterinum, Hepatinum, Pulminum

Liquid
Seroyal USA
NDC: 62106-1207

Purpose:

Uses helps promote and maintain general liver health.

Product Elements:

Cholesterinum plex cholesterinum, cholesterinum, hepatinum, pulminum alcohol cholesterol cholesterol oryctolagus cuniculus liver oryctolagus cuniculus liver oryctolagus cuniculus lung oryctolagus cuniculus lung water

Indications and Usage:

Uses helps promote and maintain general liver health. directions to be taken ten minutes away from food. invert bottle and shake lightly allowing drops to fall directly under the tongue or into Â¼ oz of water. hold contents for about 20 seconds and swallow. to promote drop flow, invert bottle and shake before each use. adults and adolescents (12 years and older) take 30 drops daily before bedtime or as recommended by your healthcare practitioner. children (under 12 years) take under the direction of your healthcare practitioner.

Warnings:

Warnings stop use and ask a doctor if symptoms persist or worsen. if pregnant or breastfeeding, ask ahealth professional before use. keep out of reach of children. in case ofoverdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions to be taken ten minutes away from food. invert bottle and shake lightly allowing drops to fall directly under the tongue or into Â¼ oz of water. hold contents for about 20 seconds and swallow. to promote drop flow, invert bottle and shake before each use. adults and adolescents (12 years and older) take 30 drops daily before bedtime or as recommended by your healthcare practitioner. children (under 12 years) take under the direction of your healthcare practitioner.

Package Label Principal Display Panel:

Ndc 62106-1207-0 unda plex cholesterinum plex homeopathic preparation helps promote and maintain general liver health. contains 25% alcohol 1 fl oz (30 ml) 62106-1207-0

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.